Total Payments
$15,397
2024 Payments
$2,204
Companies
41
Transactions
661
Medicare Patients
8,953
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$11,230 (72.9%)
Other$3,814 (24.8%)
Travel$214.73 (1.4%)
Education$111.70 (0.7%)
Gifts$27.28 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,230 | 654 | 72.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,600 | 1 | 23.4% |
| Travel and Lodging | $214.73 | 1 | 1.4% |
| Entertainment | $213.94 | 1 | 1.4% |
| Education | $111.70 | 2 | 0.7% |
| Gift | $27.28 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $4,984 | 67 | $0 (2024) |
| ABBVIE INC. | $2,752 | 154 | $0 (2024) |
| Janssen Biotech, Inc. | $1,601 | 104 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $673.99 | 52 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $519.45 | 33 | $0 (2024) |
| Medtronic, Inc. | $438.93 | 24 | $0 (2024) |
| Romark Laboratories, LC | $431.25 | 24 | $0 (2020) |
| Celgene Corporation | $429.69 | 30 | $0 (2024) |
| PFIZER INC. | $365.82 | 18 | $0 (2024) |
| Ardelyx, Inc. | $364.76 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,204 | 117 | ABBVIE INC. ($745.05) |
| 2023 | $2,468 | 137 | AbbVie Inc. ($542.55) |
| 2022 | $2,127 | 123 | ABBVIE INC. ($647.61) |
| 2021 | $1,283 | 80 | Janssen Biotech, Inc. ($619.48) |
| 2020 | $443.27 | 34 | IRONWOOD PHARMACEUTICALS, INC ($170.91) |
| 2019 | $686.73 | 46 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($213.25) |
| 2018 | $4,792 | 58 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($3,975) |
| 2017 | $1,394 | 66 | Romark Laboratories, LC ($388.46) |
All Payment Transactions
661 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: LIVER DISEASE | ||||||
| 12/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: LIVER DISEASE | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: VIROLOGY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,165 | 19,942 | $889,539 | $361,392 |
| 2022 | 31 | 2,208 | 21,872 | $977,616 | $380,397 |
| 2021 | 33 | 2,157 | 18,501 | $966,643 | $343,807 |
| 2020 | 32 | 2,423 | 19,319 | $816,603 | $276,785 |
Total Patients
8,953
Total Services
79,634
Medicare Billing
$1.4M
Procedure Codes
128
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 16 | 6,900 | $172,500 | $119,341 | 69.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 430 | 594 | $83,160 | $50,888 | 61.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 167 | 167 | $136,105 | $31,502 | 23.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 132 | 678 | $37,237 | $24,046 | 64.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 207 | 207 | $38,754 | $22,371 | 57.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 132 | 394 | $29,550 | $18,564 | 62.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 218 | 227 | $102,150 | $14,225 | 13.9% |
| 91120 | Test for tone and sensation of rectum and anus | Office | 2023 | 32 | 32 | $18,880 | $11,645 | 61.7% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 54 | 58 | $16,692 | $9,598 | 57.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 72 | 72 | $11,160 | $7,066 | 63.3% |
| 91122 | Study of rectum sensitivity and function | Office | 2023 | 31 | 31 | $9,610 | $6,237 | 64.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 34 | 34 | $19,720 | $5,795 | 29.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 93 | 93 | $63,705 | $5,528 | 8.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 58 | 80 | $6,800 | $4,724 | 69.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 43 | 43 | $49,100 | $4,062 | 8.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 24 | 35 | $7,350 | $3,120 | 42.5% |
| 74170 | Ct scan of abdomen before and after contrast | Office | 2023 | 22 | 23 | $5,220 | $2,504 | 48.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $12,180 | $2,263 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 36 | $3,600 | $1,997 | 55.5% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 13 | 16 | $21,440 | $1,950 | 9.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $8,855 | $1,769 | 20.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 19 | 50 | $2,750 | $1,761 | 64.0% |
| 43270 | Destruction of polyp or growth of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $8,965 | $1,681 | 18.8% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 38 | 40 | $2,748 | $1,609 | 58.6% |
| 74160 | Ct scan of abdomen with contrast | Office | 2023 | 11 | 11 | $2,079 | $1,331 | 64.0% |
About Dr. Samuel Tarwater, MD
Dr. Samuel Tarwater, MD is a Gastroenterology healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225080906.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Tarwater, MD has received a total of $15,397 in payments from pharmaceutical and medical device companies, with $2,204 received in 2024. These payments were reported across 661 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($11,230).
As a Medicare-enrolled provider, Tarwater has provided services to 8,953 Medicare beneficiaries, totaling 79,634 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Dothan, AL
- Active Since 05/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1225080906
Products in Payments
- XIFAXAN (Drug) $4,447
- STELARA (Biological) $1,388
- RINVOQ (Biological) $789.44
- TRULANCE (Drug) $507.78
- SKYRIZI (Biological) $480.76
- LINZESS (Drug) $477.59
- Humira (Biological) $440.61
- Linzess (Drug) $409.05
- INTERSTIM (Device) $398.72
- ZEPOSIA (Drug) $395.79
- DUPIXENT (Biological) $395.23
- Alinia Tablets 500mg 30 count bottle (Drug) $393.29
- IBSRELA (Drug) $364.76
- XELJANZ (Drug) $330.24
- ZENPEP (Drug) $289.97
- HUMIRA (Biological) $272.23
- OCALIVA (Drug) $241.31
- ENTYVIO (Biological) $237.04
- DIFICID (Drug) $213.87
- CREON (Drug) $163.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Dothan
Mr. Travis Rutland, Md, MD
Gastroenterology — Payments: $265,022
Gastroenterology $265,022
Dr. Paul Lamb, Md, MD
Gastroenterology — Payments: $111,968
Gastroenterology $111,968
Scott Sarrels, M.d, M.D
Gastroenterology — Payments: $15,718
Gastroenterology $15,718
William Mclaughlin, Md, MD
Gastroenterology — Payments: $9,913
Gastroenterology $9,913
George Nelson, M.d, M.D
Gastroenterology — Payments: $8,417
Gastroenterology $8,417
Jeffrey Crittenden, Md, MD
Gastroenterology — Payments: $8,300
Gastroenterology $8,300